Factor This Power Engineering
Live Events
DTECH⢠Events
POWERGEN®
Calendar
Resource Center
Webinars
Podcasts
White Papers
Contribute Content
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Project Development
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Utility Scale
Community
Residential
Wind Power
Turbines & Equipment
Offshore
Power Grid
Transmission
Outage Management
Grid Modernization
Smart Grids
Microgrids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Pumped Storage
Long Duration
Business
Policy & Regulation
Finance
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Resource Center
Webinars
Podcasts
Whitepapers
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zoetis
(NY:
ZTS
)
120.81
-1.76 (-1.44%)
Streaming Delayed Price
Updated: 11:32 AM EST, Dec 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Zoetis
< Previous
1
2
3
4
5
6
Next >
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
December 02, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
November 26, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 20, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Host Innovation Webcast
November 19, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces Third Quarter 2025 Results
November 04, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
November 03, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
October 29, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Appoints Stephanie Tilenius to its Board of Directors
October 28, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
October 15, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
October 10, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Declares Fourth Quarter 2025 Dividend
October 09, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
September 30, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
September 23, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
September 12, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 27, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
August 11, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
August 05, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results
July 01, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Releases 2024 Sustainability Progress Update
June 05, 2025
From
Zoetis Inc.
Via
Business Wire
Dr. Mark Stetter Elected to Zoetis Board of Directors
May 22, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Declares Third Quarter 2025 Dividend
May 21, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Participate in Upcoming Investor Conferences
May 15, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces First Quarter 2025 Results
May 06, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
March 27, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Participate in Upcoming Investor Conferences
February 20, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
February 14, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Reports Fourth Quarter and Full Year 2024 Results
February 13, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Declares Second Quarter 2025 Dividend
February 06, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
February 04, 2025
From
Zoetis Inc.
Via
Business Wire
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
January 07, 2025
From
Zoetis Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
